Recursion Reports Third Quarter 2025 Financial Results and …
Oct 9, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New …
Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia Enter ...
Aug 8, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, …
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high …
0001104659-24-100368 | PREM14A | iXBRL Viewer | Recursion ...
Only holders of record of shares of Recursion Class A Common Stock and Recursion Class B Common Stock at the close of business on the Recursion record date are entitled to receive …
Recursion Reports Second Quarter 2025 Financial Results and …
Jun 30, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New …
How a First-of-its-Kind “Microglia Map” from Recursion and Roche …
Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a …
Recursion Pharmaceuticals, Inc. - Ongoing Phase 1b/2 Trial of the ...
Dec 8, 2025 · Recursion presented a new clinical readout from the ongoing TUPELO Phase 1b/2 trial of REC-4881 in Familial Adenomatous Polyposis (FAP) at a company webinar on …
Since Its Inception, Recursion has Been Building the Foundation …
Since Recursion was founded in 2013, the company has focused on fundamentally shifting the way drugs are made using data and AI – from an emphasis on generating proprietary data …
Our Unique Approach to AI Drug Discovery | Recursion
Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects …